Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

LUNG

Pulmonx Corp

Sep 20 • 04:00PM ET

8.58

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: IWM VTI VXF IWO SCHA VTWO VHT IWC DFAS ITOT

Index	RUT	P/E	-	EPS (ttm)	-1.50	Insider Own	9.67%	Shs Outstand	38.52M	Perf Week	3.25%
Market Cap	335.91M	Forward P/E	-	EPS next Y	-1.62	Insider Trans	-0.80%	Shs Float	35.37M	Perf Month	18.67%
Income	-57.86M	PEG	-	EPS next Q	-0.45	Inst Own	88.48%	Short Float	4.47%	Perf Quarter	37.94%
Sales	76.58M	P/S	4.39	EPS this Y	-4.62%	Inst Trans	-2.46%	Short Ratio	4.87	Perf Half Y	-8.63%
Book/sh	2.58	P/B	3.32	EPS next Y	3.42%	ROA	-31.64%	Short Interest	1.58M	Perf Year	-18.67%
Cash/sh	2.93	P/C	2.93	EPS next 5Y	23.60%	ROE	-49.22%	52W Range	5.46 - 14.84	Perf YTD	-32.71%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-25.16%	ROI	-37.04%	52W High	-42.16%	Beta	0.63
Dividend TTM	-	Quick Ratio	7.92	Sales past 5Y	30.02%	Gross Margin	73.93%	52W Low	57.14%	ATR (14)	0.48
Dividend Ex-Date	-	Current Ratio	8.96	EPS Y/Y TTM	6.90%	Oper. Margin	-75.13%	RSI (14)	67.68	Volatility	5.08% 6.54%
Employees	279	Debt/Eq	0.56	Sales Y/Y TTM	26.26%	Profit Margin	-75.56%	Recom	1.33	Target Price	14.00
Option/Short	Yes / Yes	LT Debt/Eq	0.54	EPS Q/Q	8.08%	Payout	-	Rel Volume	1.26	Prev Close	8.58
Sales Surprise	3.17%	EPS Surprise	8.08%	Sales Q/Q	20.87%	Earnings	Jul 31 AMC	Avg Volume	324.60K	Price	8.58
SMA20	13.24%	SMA50	19.05%	SMA200	-6.61%	Trades		Volume	409,073	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-04-24	Initiated	Lake Street	Buy	$12
Feb-23-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$16 → $14
Sep-05-23	Initiated	Craig Hallum	Buy	$18
Feb-27-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$10 → $15
Jan-03-23	Downgrade	BofA Securities	Neutral → Underperform	$8
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$14 → $10
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$23 → $19
Mar-02-22	Resumed	BofA Securities	Neutral	$28
Dec-08-21	Upgrade	Piper Sandler	Neutral → Overweight	$45
Apr-01-21	Initiated	Citigroup	Buy	$60
Mar-25-21	Initiated	Piper Sandler	Neutral	$50
Mar-10-21	Upgrade	BofA Securities	Neutral → Buy	$72
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Oct-26-20	Initiated	Wells Fargo	Equal Weight	$46
Oct-26-20	Initiated	Stifel	Buy	$50
Oct-26-20	Initiated	Morgan Stanley	Equal-Weight	$44
Oct-26-20	Initiated	Canaccord Genuity	Buy	$49
Oct-26-20	Initiated	BofA Securities	Buy	$50

Show Previous Ratings

Sep-09-24 04:05PM	Pulmonx Announces Presentation of Clinical Data from the AeriSeal CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 (GlobeNewswire) +9.00%
Aug-29-24 04:05PM	Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-22-24 04:05PM	Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference (GlobeNewswire) +9.32%
Jul-31-24 05:50PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.08%
04:05PM	Pulmonx Reports Second Quarter 2024 Financial Results (GlobeNewswire)
04:05PM	Loading…
Jul-29-24 04:05PM	Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) -9.16%
Jul-10-24 04:05PM	Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024 (GlobeNewswire) +13.86%
May-22-24 09:55AM	How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3% (Zacks)
May-06-24 05:03PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.50%
09:55AM	Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High? (Zacks)
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +21.50%
07:05AM	Q1 2024 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
03:38AM	Pulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ... (GuruFocus.com)
May-01-24 08:55PM	LUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Loading…
06:05PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:46PM	Pulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued Losses (GuruFocus.com)
04:05PM	Pulmonx Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-10-24 04:05PM	Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 (GlobeNewswire)
Apr-02-24 04:05PM	Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer (GlobeNewswire) -6.79% -6.58%
Mar-15-24 05:00PM	Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-29-24 11:35PM	Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
Feb-26-24 08:00AM	Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal Trial (Business Wire)
Feb-22-24 09:55AM	Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript (Insider Monkey) -18.21%
06:56AM	Q4 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:44PM	Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses (GuruFocus.com)
04:06PM	Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
04:05PM	Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer (GlobeNewswire)
Feb-17-24 12:08AM	Insider Sell: President and CEO French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Feb-13-24 01:08PM	PRIMECAP Management Bolsters Position in Pulmonx Corp (GuruFocus.com)
04:05PM	Loading…
Feb-07-24 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 (GlobeNewswire)
Dec-22-23 11:19PM	Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG) (GuruFocus.com)
Dec-11-23 09:00AM	The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors (GlobeNewswire)
Nov-17-23 01:08PM	Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare (InvestorPlace)
Nov-15-23 04:05PM	Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Oct-31-23 04:05PM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire) +11.41%
09:00AM	Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:03AM	Q3 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-30-23 06:30PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:53PM	Pulmonx Corp (LUNG) Reports Record Q3 2023 Financial Results (GuruFocus.com)
04:05PM	Pulmonx Reports Record Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-16-23 04:05PM	Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023 (GlobeNewswire)
Oct-10-23 04:05PM	Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue (GlobeNewswire) -13.36%
Aug-30-23 04:05PM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire)
Aug-02-23 05:55PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:05PM	Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire) +7.23%
Jul-19-23 04:05PM	Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023 (GlobeNewswire)
Jul-17-23 08:00AM	Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023 (GlobeNewswire)
Jul-10-23 08:47AM	Shareholders in Pulmonx (NASDAQ:LUNG) are in the red if they invested a year ago (Simply Wall St.)
May-03-23 10:43AM	Q1 2023 Pulmonx Corp Earnings Call (Thomson Reuters StreetEvents) +8.63%
May-02-23 05:35PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.90%
04:05PM	Pulmonx Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 08:24PM	7 Nasdaq Small-Cap Stocks Set to Outperform in 2023 (InvestorPlace)
Apr-25-23 04:05PM	Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference (GlobeNewswire) -5.57%
Apr-18-23 04:05PM	Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023 (Business Wire)
Apr-17-23 02:20PM	Pulmonx Corporation (NASDAQ:LUNG) Not Flying Under The Radar (Simply Wall St.) +6.06%
Feb-24-23 04:00PM	Why Shares of Pulmonx Rose This Week (Motley Fool) +5.98%
Feb-22-23 05:55PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +20.21%
04:05PM	Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-16-23 04:05PM	Pulmonx to Present at the Citi 2023 Healthcare Conference (GlobeNewswire)
Feb-08-23 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023 (GlobeNewswire)
Jan-31-23 06:57AM	Pulmonx (NASDAQ:LUNG) investors are sitting on a loss of 66% if they invested a year ago (Simply Wall St.)
Dec-14-22 04:05PM	American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema (Business Wire)
Nov-30-22 07:00AM	Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema (Business Wire) +12.73%
Nov-16-22 04:05PM	Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference (GlobeNewswire) -8.61%
Nov-11-22 05:12AM	Pulmonx Corporation (NASDAQ:LUNG) Analysts Just Slashed Next Year's Revenue Estimates By 21% (Simply Wall St.) +14.36%
Nov-09-22 06:27AM	Pulmonx Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.) -7.16%
Nov-04-22 12:34PM	Why Pulmonx Stock Is Crashing Today (Motley Fool) -60.94%
08:00AM	Pulmonx to Participate at Upcoming Investor Conferences (GlobeNewswire)
Nov-03-22 06:45PM	Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -9.53%
04:05PM	Pulmonx Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-27-22 10:02AM	Earnings Preview: Pulmonx Corporation (LUNG) Q3 Earnings Expected to Decline (Zacks) -5.15%
Oct-20-22 04:05PM	Pulmonx to Report Third Quarter 2022 Financial Results on November 3, 2022 (GlobeNewswire)
Oct-14-22 10:01AM	3 Medical Info System Stocks to Gain on Rising Demand for Digital Health (Zacks)
Oct-13-22 09:35AM	Down 27.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Pulmonx Corporation (LUNG) (Zacks)
Sep-09-22 03:29PM	ADDING and REPLACING CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema (Business Wire)
Aug-24-22 04:05PM	Pulmonx to Present at Upcoming September Investor Conferences (Business Wire)
Aug-03-22 09:55AM	Wall Street Analysts Predict a 79% Upside in Pulmonx Corporation (LUNG): Here's What You Should Know (Zacks)
Aug-02-22 11:00PM	Pulmonx Corporation (LUNG) Q2 2022 Earnings Call Transcript (Motley Fool) +5.60%
05:35PM	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-27-22 04:05PM	Pulmonx to Present at the Canaccord Genuity 42nd Annual Growth Conference (Business Wire)
Jul-19-22 04:05PM	Pulmonx to Report Second Quarter 2022 Financial Results on August 2, 2022 (Business Wire)
Jul-18-22 09:55AM	Can Pulmonx Corporation (LUNG) Climb 117% to Reach the Level Wall Street Analysts Expect? (Zacks)
05:15AM	Analysts Just Trimmed Their Price Targets of These 10 Stocks (Insider Monkey)
Jul-06-22 08:10AM	Privia Health (PRVA) Moves 7.4% Higher: Will This Strength Last? (Zacks)
Jun-26-22 08:36AM	Pulmonx (NASDAQ:LUNG) shareholders are up 11% this past week, but still in the red over the last year (Simply Wall St.)
May-03-22 10:00PM	Pulmonx Corporation (LUNG) Q1 2022 Earnings Call Transcript (Motley Fool)
05:35PM	Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports First Quarter 2022 Financial Results (GlobeNewswire)
Apr-26-22 04:05PM	Pulmonx to Present at the Bank of America Securities 2022 Healthcare Conference (GlobeNewswire) -6.14%
Apr-19-22 04:05PM	Pulmonx to Report First Quarter 2022 Financial Results on May 3, 2022 (GlobeNewswire) +7.46%
Feb-23-22 11:00PM	Pulmonx Corporation (LUNG) Q4 2021 Earnings Call Transcript (Motley Fool)
06:35PM	Pulmonx Corporation (LUNG) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Pulmonx Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Feb-10-22 04:05PM	Pulmonx to Present at the Citi 2022 Virtual Healthcare Conference (GlobeNewswire)
Feb-09-22 04:05PM	Pulmonx to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022 (GlobeNewswire)
Jan-27-22 05:38PM	Siguler Guff Advisers, Llc Buys Fathom Digital Manufacturing Corp, Frontier Communications ... (GuruFocus.com) -5.76% +5.65%
Jan-17-22 06:36AM	Investors one-year losses grow to 53% as the stock sheds US$91m this past week (Simply Wall St.)

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
French Glendon E. III	Director	Sep 12 '24	Sale	8.09	20,000	161,800	1,111,974	Sep 18 06:08 PM
GLENDON FRENCH	Director	Sep 12 '24	Proposed Sale	7.75	20,000	155,000		Sep 12 04:32 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Sep 03 '24	Sale	6.70	4,586	30,721	295,433	Sep 05 06:10 PM
Lehman David Aaron	GENERAL COUNSEL	Sep 03 '24	Sale	6.69	5,765	38,576	203,348	Sep 05 06:08 PM
Williamson Steven S.	PRESIDENT AND CEO	Aug 20 '24	Buy	6.84	14,245	97,436	219,531	Aug 22 06:41 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Jun 24 '24	Sale	6.16	1,184	7,293	300,019	Jun 26 06:07 PM
Lehman David Aaron	GENERAL COUNSEL	Jun 03 '24	Sale	6.97	5,475	38,161	209,113	Jun 05 05:59 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Jun 03 '24	Sale	6.97	4,297	29,950	301,203	Jun 05 05:58 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	May 22 '24	Sale	8.71	1,184	10,313	305,500	May 23 06:07 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Apr 22 '24	Sale	7.49	1,184	8,868	306,684	Apr 24 06:14 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Mar 22 '24	Sale	9.36	1,184	11,082	307,868	Mar 26 05:53 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Mar 01 '24	Sale	9.06	3,097	28,059	239,952	Mar 05 06:22 PM
McKune John	INTERIM CFO	Mar 01 '24	Sale	9.06	1,078	9,767	47,410	Mar 05 06:20 PM
Lehman David Aaron	GENERAL COUNSEL	Mar 01 '24	Sale	9.06	4,351	39,420	145,488	Mar 05 06:18 PM
French Glendon E. III	PRESIDENT AND CEO	Mar 01 '24	Sale	9.06	6,954	63,003	1,116,758	Mar 05 06:15 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Feb 22 '24	Sale	14.20	1,184	16,813	243,049	Feb 26 06:23 PM
French Glendon E. III	PRESIDENT AND CEO	Feb 15 '24	Sale	14.60	20,000	292,000	1,121,344	Feb 16 07:11 PM
Rose Geoffrey Beran	CHIEF COMMERCIAL OFFICER	Jan 22 '24	Sale	13.13	1,184	15,546	244,233	Jan 24 05:41 PM
French Glendon E. III	PRESIDENT AND CEO	Jan 18 '24	Sale	12.77	10,000	127,700	1,141,344	Jan 22 06:05 PM
Rose Geoffrey Beran	Chief Commercial Officer	Dec 22 '23	Sale	12.75	1,184	15,096	245,417	Dec 27 04:19 PM
French Glendon E. III	President and CEO	Dec 21 '23	Sale	12.42	10,000	124,200	1,151,344	Dec 22 06:12 PM
Rose Geoffrey Beran	Chief Commercial Officer	Dec 01 '23	Sale	10.34	2,868	29,655	246,601	Dec 05 05:46 PM
McKune John	Interim CFO	Dec 01 '23	Sale	10.34	942	9,739	40,414	Dec 05 05:44 PM
Lehman David Aaron	General Counsel	Dec 01 '23	Sale	10.34	3,809	39,381	149,839	Dec 05 05:42 PM
French Glendon E. III	President and CEO	Dec 01 '23	Sale	10.34	6,676	69,030	1,161,344	Dec 05 05:41 PM
Rose Geoffrey Beran	Chief Commercial Officer	Nov 22 '23	Sale	10.60	1,184	12,550	249,469	Nov 27 06:14 PM
Rose Geoffrey Beran	Chief Commercial Officer	Oct 23 '23	Sale	8.35	1,184	9,886	250,653	Oct 25 06:20 PM
Rose Geoffrey Beran	Chief Commercial Officer	Sep 22 '23	Sale	10.51	1,184	12,444	251,837	Sep 26 06:15 PM

Open in Screener

OM

Outset Medical Inc

Sep 20 • 04:00PM ET

0.5732

Dollar change -0.0209
Percentage change -3.52	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VXF SCHA VHT IWC PRFZ SCHB BTEC

Index	-	P/E	-	EPS (ttm)	-3.14	Insider Own	8.27%	Shs Outstand	50.32M	Perf Week	8.15%
Market Cap	29.86M	Forward P/E	-	EPS next Y	-1.39	Insider Trans	-1.92%	Shs Float	47.78M	Perf Month	-16.93%
Income	-159.18M	PEG	-	EPS next Q	-0.44	Inst Own	96.13%	Short Float	8.17%	Perf Quarter	-86.76%
Sales	116.42M	P/S	0.26	EPS this Y	28.15%	Inst Trans	-5.03%	Short Ratio	1.89	Perf Half Y	-72.57%
Book/sh	1.32	P/B	0.44	EPS next Y	28.22%	ROA	-49.06%	Short Interest	3.90M	Perf Year	-95.15%
Cash/sh	3.74	P/C	0.15	EPS next 5Y	-	ROE	-126.48%	52W Range	0.44 - 12.45	Perf YTD	-89.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-15.08%	ROI	-59.13%	52W High	-95.40%	Beta	1.91
Dividend TTM	-	Quick Ratio	5.38	Sales past 5Y	202.67%	Gross Margin	28.23%	52W Low	31.77%	ATR (14)	0.11
Dividend Ex-Date	-	Current Ratio	6.80	EPS Y/Y TTM	10.36%	Oper. Margin	-129.25%	RSI (14)	30.43	Volatility	16.84% 12.57%
Employees	480	Debt/Eq	2.95	Sales Y/Y TTM	-9.94%	Profit Margin	-136.72%	Recom	2.25	Target Price	3.18
Option/Short	Yes / Yes	LT Debt/Eq	2.92	EPS Q/Q	26.19%	Payout	-	Rel Volume	0.38	Prev Close	0.59
Sales Surprise	-12.14%	EPS Surprise	-5.31%	Sales Q/Q	-24.01%	Earnings	Aug 07 AMC	Avg Volume	2.06M	Price	0.57
SMA20	1.63%	SMA50	-70.23%	SMA200	-82.18%	Trades		Volume	783,298	Change	-3.52%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-08-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$6 → $3
Jun-21-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$5 → $6
Apr-08-24	Initiated	BTIG Research	Buy	$6
Apr-05-24	Upgrade	CL King	Neutral → Buy	$6
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$14 → $6
Oct-13-23	Downgrade	BofA Securities	Buy → Underperform	$32 → $3
Aug-17-23	Initiated	CL King	Neutral
Nov-11-22	Initiated	RBC Capital Mkts	Outperform	$23
Jul-14-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$48 → $20
Mar-02-22	Resumed	BofA Securities	Buy	$50
Feb-17-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$50
Aug-18-21	Initiated	Cowen	Outperform	$70
Apr-19-21	Initiated	Wells Fargo	Overweight	$63
Dec-16-20	Initiated	Oppenheimer	Perform
Oct-12-20	Initiated	SVB Leerink	Mkt Perform	$60
Oct-12-20	Initiated	Stifel	Buy	$54
Oct-12-20	Initiated	Morgan Stanley	Equal-Weight	$48
Oct-12-20	Initiated	Goldman	Buy	$54
Oct-12-20	Initiated	BofA Securities	Buy	$54
Oct-12-20	Initiated	Barclays	Overweight

Show Previous Ratings

Today 09:13AM	Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman (GlobeNewswire)
Sep-17-24 05:45AM	Outset Medical, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire)
Sep-13-24 05:45AM	Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM (PR Newswire) +17.67%
Sep-12-24 01:23AM	Analysis of AMERIPRISE FINANCIAL INC's Recent Trade in Outset Medical Inc (GuruFocus.com) -11.69%
01:14AM	Morgan Stanley's Strategic Reduction in Outset Medical Inc Shares (GuruFocus.com)
01:08AM	Loading…
01:08AM	JPMorgan Chase & Co's Strategic Reduction in Outset Medical Inc (GuruFocus.com)
Sep-11-24 03:44PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (Newsfile)
Sep-09-24 04:10PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Sep-06-24 01:47PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Sep-04-24 03:23PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (Newsfile)
Sep-03-24 11:57AM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Aug-31-24 05:52PM	Outset Medical (OM) Faces Investor Scrutiny After FDA Warning Letter Leads to Poor Financial Results - Hagens Berman (GlobeNewswire)
Aug-26-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, BrightSpring, Outset, and NuScale and Encourages Investors to Contact the Firm (GlobeNewswire) -5.28%
Aug-07-24 06:35PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -68.53%
04:03PM	Outset Medical Reports Second Quarter 2024 Financial Results (Business Wire)
10:01AM	Loading…
Jul-31-24 10:01AM	Will Outset Medical, Inc. (OM) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-24-24 09:00AM	Outset Medical to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 (Business Wire) -5.65%
Jul-01-24 06:00AM	3 MedTech Stocks to Buy for Healthy Gains (InvestorPlace)
Jun-10-24 12:00PM	Outset Medical (OM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) -8.44%
Jun-03-24 04:05PM	Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
May-13-24 06:59AM	Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating (MT Newswires)
May-10-24 03:48PM	Outset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens Losses (GuruFocus.com) -6.12%
May-09-24 03:44PM	Outset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call Transcript (Insider Monkey) -20.82%
09:42AM	Q1 2024 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
03:57AM	Outset Medical Inc (OM) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
May-08-24 08:58PM	OM Stock Earnings: Outset Medical Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +8.97%
05:45PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:02PM	Outset Medical Reports First Quarter 2024 Financial Results (Business Wire)
May-06-24 08:48AM	Outset Medical Receives US FDA 510(k) Clearance for TabloCart With Prefiltration -- Shares Surge 13% Pre-Bell (MT Newswires) +20.70%
08:00AM	Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance (Business Wire)
09:43AM	Loading…
May-03-24 09:43AM	Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 04:30PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire) +12.65% +5.26%
Apr-19-24 08:30AM	Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (Business Wire)
Apr-18-24 01:36PM	Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis (Zacks)
Apr-17-24 08:30AM	Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S. (Business Wire)
Apr-15-24 08:30AM	Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care (Business Wire)
Mar-13-24 04:02PM	Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors (Business Wire) -10.70%
Mar-05-24 03:34PM	Why Dialysis Stocks Are up Today (The Wall Street Journal)
Feb-26-24 09:00AM	Outset Medical to Present at the 44th Annual TD Cowen Health Care Conference (Business Wire)
Feb-22-24 10:51AM	Outset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call Transcript (Insider Monkey) +6.23%
07:10AM	Q4 2023 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:49PM	Outset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 Results (GuruFocus.com)
04:05PM	Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-20-24 04:25PM	ROLLINS, INC. ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS (PR Newswire)
Feb-05-24 10:00AM	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) +5.76%
08:30AM	Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024 (Business Wire)
Jan-08-24 08:30AM	Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance (Business Wire)
Jan-03-24 08:30AM	Outset Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-29-23 04:05PM	Outset Medical to Present at BofA Home Care Conference (Business Wire) +5.70%
Nov-25-23 11:43AM	5 Struggling Stocks to Buy at a Discount (Motley Fool)
Nov-23-23 06:30AM	2 of the Cheapest Stocks I Own (Motley Fool)
Nov-16-23 02:46PM	Outset Medical (OM) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Losses to Contact the Firm's Attorneys (GlobeNewswire)
Nov-09-23 04:05PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire)
Nov-07-23 04:31PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire) -14.39%
04:05PM	Outset Medical Reports Third Quarter 2023 Financial Results (Business Wire)
Nov-02-23 10:00AM	Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for (Zacks) +7.18%
09:35AM	After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM) (Zacks)
Nov-01-23 09:00AM	New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo Hemodialysis System on Equitable Kidney Care (Business Wire) +6.21%
Oct-31-23 02:00PM	Outset Medical (OM) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Losses to Contact the Firm (GlobeNewswire) +15.31%
10:01AM	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-30-23 04:05PM	Outset Medical to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023 (Business Wire)
Oct-27-23 11:42AM	Hagens Berman Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
Oct-19-23 12:31PM	Outset Medical (PM) Investigated for Possible Securities Law Violations, Hagens Berman Encourages Investors with Losses to Contact its Attorneys (GlobeNewswire) -6.67%
Oct-17-23 05:36PM	Outset Medical, Inc.: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
09:35AM	Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM) (Zacks)
Oct-16-23 08:14AM	Outset Medical, Inc. (NASDAQ:OM) Q3 2023 Earnings Call Transcript (Insider Monkey) +15.04%
Oct-13-23 07:21PM	Outset Medical stock nosedives due to FDA warning letter headwinds Hagens Berman (GlobeNewswire) -49.93%
09:50AM	Netflix downgraded, Applied Materials upgraded: Wall Street's top analyst calls (The Fly)
Oct-12-23 04:05PM	Outset Medical Reports Preliminary Third Quarter 2023 Financial Results (Business Wire) -11.33%
Aug-29-23 04:05PM	Outset Medical to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire)
Aug-14-23 09:24PM	Investors Look at Apple, Amazon, and More (Motley Fool)
Aug-02-23 05:55PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -10.18%
04:05PM	Outset Medical Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-13-23 08:30AM	Outset Medical to Report Second Quarter 2023 Financial Results on Wednesday, August 2, 2023 (Business Wire)
Jul-10-23 01:09PM	Why Shares of Outset Medical Are Down Monday (Motley Fool) -5.87%
10:48AM	Shareholders in These 2 Stocks Got Nasty Surprises Monday (Motley Fool)
Jun-15-23 06:56AM	Getting In Cheap On Outset Medical, Inc. (NASDAQ:OM) Might Be Difficult (Simply Wall St.)
Jun-06-23 04:05PM	Outset Medical to Present at Goldman Sachs 44th Annual Global Healthcare Conference (Business Wire) +6.06%
May-30-23 07:30AM	The Ultimate Growth Stocks to Buy With $1,400 Right Now (Motley Fool)
May-05-23 06:14AM	Outset Medical First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
May-04-23 09:13AM	Q1 2023 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
May-03-23 06:35PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +5.02%
04:05PM	Outset Medical Reports First Quarter 2023 Financial Results (Business Wire)
Apr-30-23 05:50AM	Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade. (Motley Fool)
Apr-25-23 08:30AM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire)
Apr-23-23 07:03AM	This Could Be the Best Growth Stock Under $20 on the Market Right Now (Motley Fool)
Apr-12-23 09:05AM	Outset Medical to Present Research Highlighting Home Hemodialysis Success for Underserved Populations at National Kidney Foundation Spring Clinical Meetings (Business Wire)
08:30AM	Outset Medical to Report First Quarter 2023 Financial Results on Wednesday, May 3, 2023 (Business Wire)
Apr-03-23 07:01AM	Outset Medical (NASDAQ:OM) investors are sitting on a loss of 61% if they invested a year ago (Simply Wall St.)
Mar-25-23 08:26AM	There's More to the Mint Mobile Deal Than Ryan Reynolds (Motley Fool)
Feb-22-23 04:05PM	Outset Medical to Present at 43rd Annual Cowen Health Care Conference (Business Wire)
Feb-17-23 04:16PM	Outset Medical, Inc. (NASDAQ:OM) Q4 2022 Earnings Call Transcript (Insider Monkey) -6.77%
Feb-15-23 05:54AM	Better Medtech Stock to Buy: InMode or Outset Medical? (Motley Fool) -6.06%
Feb-14-23 12:10PM	Why Shares of Outset Medical Are Down Tuesday (Motley Fool) -5.94%
Feb-13-23 05:45PM	Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Outset Medical Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Feb-07-23 10:00AM	Computer Programs and Systems (CPSI) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-06-23 10:00AM	Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jan-25-23 08:30AM	Outset Medical to Report Fourth Quarter and Full Year 2022 Financial Results on Monday, February 13, 2023 (Business Wire)
Jan-09-23 08:30AM	Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross Margin Guidance (Business Wire)

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Trigg Leslie	Chair and CEO	Aug 15 '24	Sale	0.84	5,308	4,459	910,496	Aug 15 08:02 PM
Nash Marc	SVP Operations and R&D	Aug 15 '24	Sale	0.84	1,293	1,086	239,397	Aug 15 08:01 PM
Brottem John L.	General Counsel	Aug 15 '24	Sale	0.84	3,011	2,529	230,295	Aug 15 07:59 PM
Ahmed Nabeel	Chief Financial Officer	Aug 15 '24	Sale	0.84	3,971	3,336	314,988	Aug 15 07:57 PM
Trigg Leslie	Officer	Aug 15 '24	Proposed Sale	0.84	5,308	4,459		Aug 15 06:49 PM
Nash Marc	Officer	Aug 15 '24	Proposed Sale	0.84	1,293	1,086		Aug 15 06:49 PM
Brottem John L.	Officer	Aug 15 '24	Proposed Sale	0.84	3,011	2,529		Aug 15 06:47 PM
Ahmed Nabeel	Officer	Aug 15 '24	Proposed Sale	0.84	3,971	3,336		Aug 15 06:46 PM
Nash Marc	SVP Operations and R&D	Jul 24 '24	Sale	4.02	723	2,906	240,690	Jul 24 07:08 PM
Brottem John L.	General Counsel	Jun 12 '24	Sale	4.78	10,569	50,520	233,306	Jun 14 04:17 PM
GROSSMAN D KEITH	Director	Jun 03 '24	Option Exercise	1.11	69,303	76,926	85,922	Jun 03 06:57 PM
GROSSMAN D KEITH	Director	Jun 03 '24	Sale	3.78	38,117	144,234	47,805	Jun 03 06:57 PM
Ahmed Nabeel	Chief Financial Officer	May 16 '24	Sale	3.53	3,918	13,831	318,959	May 17 05:40 PM
Nash Marc	SVP Operations and R&D	May 16 '24	Sale	3.53	1,097	3,872	241,413	May 17 05:38 PM
Brottem John L.	General Counsel	May 16 '24	Sale	3.53	2,972	10,491	243,875	May 17 05:36 PM
Trigg Leslie	Chair and CEO	May 16 '24	Sale	3.53	5,237	18,487	915,804	May 17 05:25 PM
Racine Jean-Olivier	Chief Technology Officer	May 10 '24	Sale	3.27	8,306	27,161	265,325	May 10 06:19 PM
Nash Marc	SVP Operations and R&D	Mar 15 '24	Sale	2.13	2,391	5,093	242,510	Mar 15 06:40 PM
Ahmed Nabeel	Chief Financial Officer	Mar 01 '24	Sale	3.15	1,584	4,990	322,877	Mar 04 04:34 PM
Williamson Steven S.	Chief Commercial Officer	Feb 15 '24	Sale	3.57	2,500	8,925	320,347	Feb 16 05:31 PM
Trigg Leslie	Chair and CEO	Feb 15 '24	Sale	3.57	5,320	18,992	833,091	Feb 16 05:29 PM
Racine Jean-Olivier	Chief Technology Officer	Feb 15 '24	Sale	3.57	1,866	6,662	271,830	Feb 16 05:28 PM
Nash Marc	SVP Operations and R&D	Feb 15 '24	Sale	3.57	617	2,203	243,100	Feb 16 05:27 PM
Brottem John L.	General Counsel	Feb 15 '24	Sale	3.57	3,341	11,927	245,046	Feb 16 05:26 PM
Ahmed Nabeel	Chief Financial Officer	Feb 15 '24	Sale	3.57	4,403	15,719	312,594	Feb 16 05:24 PM
Williamson Steven S.	Chief Commercial Officer	Jan 16 '24	Sale	4.29	996	4,273	322,847	Jan 17 08:04 PM
Trigg Leslie	Chair and CEO	Jan 16 '24	Sale	4.29	8,126	34,861	838,411	Jan 17 08:03 PM
Racine Jean-Olivier	Chief Technology Officer	Jan 16 '24	Sale	4.29	723	3,102	273,696	Jan 17 08:03 PM
Porter Stacey L.	Chief People Officer	Jan 16 '24	Sale	4.29	768	3,295	61,448	Jan 17 08:02 PM
Nash Marc	SVP Operations and R&D	Jan 16 '24	Sale	429.00	678	290,862	243,717	Jan 17 08:01 PM
Brottem John L.	General Counsel	Jan 16 '24	Sale	4.29	1,480	6,349	248,387	Jan 17 08:00 PM
Ahmed Nabeel	Chief Financial Officer	Jan 16 '24	Sale	4.29	1,726	7,405	316,997	Jan 17 07:59 PM
Williamson Steven S.	Chief Commercial Officer	Jan 08 '24	Sale	5.49	7,055	38,732	105,939	Jan 08 08:35 PM
Trigg Leslie	Chair and CEO	Jan 08 '24	Sale	5.49	14,188	77,892	389,099	Jan 08 08:34 PM
Racine Jean-Olivier	Chief Technology Officer	Jan 08 '24	Sale	5.49	3,905	21,438	73,781	Jan 08 08:33 PM
Porter Stacey L.	Chief People Officer	Jan 08 '24	Sale	5.49	4,766	26,165	58,630	Jan 08 08:31 PM
Brottem John L.	General Counsel	Jan 08 '24	Sale	5.49	7,344	40,319	48,807	Jan 08 08:30 PM
Ahmed Nabeel	Chief Financial Officer	Jan 08 '24	Sale	5.49	10,709	58,792	76,819	Jan 08 08:29 PM
Williamson Steven S.	Chief Commercial Officer	Nov 16 '23	Sale	4.76	3,584	17,060	112,994	Nov 17 04:22 PM
Trigg Leslie	Chair and CEO	Nov 16 '23	Sale	4.76	3,175	15,113	403,287	Nov 17 04:19 PM
Racine Jean-Olivier	Chief Technology Officer	Nov 16 '23	Sale	4.76	790	3,760	77,686	Nov 17 04:18 PM
Porter Stacey L.	Chief People Officer	Nov 16 '23	Sale	4.76	671	3,194	63,396	Nov 17 04:17 PM
Nash Marc	SVP Operations and R&D	Nov 16 '23	Sale	4.76	562	2,675	44,757	Nov 17 04:15 PM
Brottem John L.	General Counsel	Nov 16 '23	Sale	4.76	1,431	6,812	56,151	Nov 17 04:15 PM
Ahmed Nabeel	Chief Financial Officer	Nov 16 '23	Sale	4.76	1,643	7,821	87,528	Nov 17 04:08 PM

LUNG

Pulmonx Corp

OM

Outset Medical Inc

Upgrade your FINVIZ experience